Detalles de la búsqueda
1.
MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samples.
Brief Bioinform
; 24(2)2023 03 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36653909
2.
Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial.
Breast Cancer Res
; 23(1): 38, 2021 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33761970
3.
Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer.
Int J Mol Sci
; 22(9)2021 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33925233
4.
Potential through simplicity: thymidine kinase-1 as a biomarker for CDK4/6 inhibitors.
Br J Cancer
; 123(2): 176-177, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32382111
5.
Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial.
Breast Cancer Res
; 21(1): 71, 2019 05 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31142370
6.
ddSeeker: a tool for processing Bio-Rad ddSEQ single cell RNA-seq data.
BMC Genomics
; 19(1): 960, 2018 Dec 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-30583719
7.
A gene expression signature of Retinoblastoma loss-of-function predicts resistance to neoadjuvant chemotherapy in ER-positive/HER2-positive breast cancer patients.
Breast Cancer Res Treat
; 170(2): 329-341, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29564743
8.
Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers.
BMC Med
; 13: 46, 2015 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-25857348
9.
Cyclin-dependent kinase 4/6 inhibitors in breast cancer therapy.
Curr Opin Oncol
; 26(6): 568-75, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25188473
10.
Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial.
JCO Precis Oncol
; 8: e2300285, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38427931
11.
Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER+ breast cancer.
Sci Transl Med
; 16(736): eadf9874, 2024 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38416843
12.
Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor-positive Breast Cancer.
Clin Cancer Res
; 30(9): 1889-1905, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38381406
13.
Novel endocrine therapies: What is next in estrogen receptor positive, HER2 negative breast cancer?
Cancer Treat Rev
; 117: 102569, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37146385
14.
Risk assessment of disease recurrence in early breast cancer: A serum metabolomic study focused on elderly patients.
Transl Oncol
; 27: 101585, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36403505
15.
Serum thymidine kinase activity in patients with HR-positive/HER2-negative advanced breast cancer treated with ribociclib plus letrozole: Results from the prospective BioItaLEE trial.
Eur J Cancer
; 186: 1-11, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37003098
16.
PIK3CA co-occurring mutations and copy-number gain in hormone receptor positive and HER2 negative breast cancer.
NPJ Breast Cancer
; 8(1): 24, 2022 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35181669
17.
Serum thymidine kinase activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with palbociclib and fulvestrant.
Eur J Cancer
; 164: 39-51, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35172272
18.
CDK4/6 inhibitors: A focus on biomarkers of response and post-treatment therapeutic strategies in hormone receptor-positive HER2-negative breast cancer.
Cancer Treat Rev
; 93: 102136, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33360919
19.
Charting differentially methylated regions in cancer with Rocker-meth.
Commun Biol
; 4(1): 1249, 2021 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34728774
20.
Circulating Biomarkers of CDK4/6 Inhibitors Response in Hormone Receptor Positive and HER2 Negative Breast Cancer.
Cancers (Basel)
; 13(11)2021 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34072070